10x Genomics, Inc. (TXG) Q1 2024 Earnings
TXG·Reported April 30, 2024·After market close
10x Genomics, Inc. reported Q1 2024 revenue of $141.0M, missed analyst consensus of $142.2M by $1.2M. Diluted EPS came in at $-0.50, missed the $-0.46 consensus by $0.04.
Revenue
$141.0Mmissed by $1.2M
Consensus: $142.2MDiluted EPS
$-0.50missed by $0.04
Consensus: $-0.46
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about 10x Genomics, Inc.'s Q1 2024 earnings report.
10x Genomics, Inc. (TXG) reported Q1 2024 earnings on April 30, 2024 after market close.
10x Genomics, Inc. reported revenue of $141.0M and diluted EPS of $-0.50 for Q1 2024.
Revenue missed the consensus estimate of $142.2M by $1.2M. EPS missed the consensus estimate of $-0.46 by $0.04.
You can read the 10-Q periodic report (0001770787-24-000036) directly on SEC EDGAR. The filing index links above go to sec.gov.